vs
Healthpeak Properties（DOC）与滨特尔（PNR）财务数据对比。点击上方公司名可切换其他公司
滨特尔的季度营收约是Healthpeak Properties的1.5倍（$1.0B vs $702.9M），Healthpeak Properties净利率更高（51.6% vs 16.6%，领先35.0%），滨特尔同比增速更快（2.6% vs -6.6%），过去两年Healthpeak Properties的营收复合增速更高（0.5% vs -2.9%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
滨特尔（股票代码PNR）是知名水处理企业，注册地位于爱尔兰，税务居民身份归属英国，美国区总部设于明尼苏达州金谷市。品牌起源于美国，2017年数据显示其65%的营收来自美国和加拿大，2014年集团完成架构重组，注册地由瑞士变更为爱尔兰。
DOC vs PNR — 直观对比
营收规模更大
PNR
是对方的1.5倍
$702.9M
营收增速更快
PNR
高出9.3%
-6.6%
净利率更高
DOC
高出35.0%
16.6%
两年增速更快
DOC
近两年复合增速
-2.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $1.0B |
| 净利润 | $363.0M | $172.4M |
| 毛利率 | — | 41.8% |
| 营业利润率 | 0.7% | 20.3% |
| 净利率 | 51.6% | 16.6% |
| 营收同比 | -6.6% | 2.6% |
| 净利润同比 | 28.3% | 11.3% |
| 每股收益（稀释后） | $0.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCPNR
| Q1 26 | $702.9M | $1.0B | ||
| Q4 25 | $719.4M | $1.0B | ||
| Q3 25 | $705.9M | $1.0B | ||
| Q2 25 | $694.3M | $1.1B | ||
| Q1 25 | $702.9M | $1.0B | ||
| Q4 24 | $698.0M | $972.9M | ||
| Q3 24 | $700.4M | $993.4M | ||
| Q2 24 | $695.5M | $1.1B |
净利润DOCPNR
| Q1 26 | $363.0M | $172.4M | ||
| Q4 25 | $114.0M | $166.1M | ||
| Q3 25 | $-117.1M | $184.3M | ||
| Q2 25 | $31.7M | $148.5M | ||
| Q1 25 | $42.8M | $154.9M | ||
| Q4 24 | $4.5M | $166.4M | ||
| Q3 24 | $85.9M | $139.6M | ||
| Q2 24 | $146.0M | $186.1M |
毛利率DOCPNR
| Q1 26 | — | 41.8% | ||
| Q4 25 | — | 40.4% | ||
| Q3 25 | 58.6% | 41.0% | ||
| Q2 25 | 60.2% | 40.7% | ||
| Q1 25 | 61.1% | 39.9% | ||
| Q4 24 | 60.3% | 38.8% | ||
| Q3 24 | 60.0% | 39.6% | ||
| Q2 24 | 60.6% | 39.8% |
营业利润率DOCPNR
| Q1 26 | 0.7% | 20.3% | ||
| Q4 25 | 17.4% | 20.1% | ||
| Q3 25 | 9.2% | 22.7% | ||
| Q2 25 | 5.7% | 19.4% | ||
| Q1 25 | 7.7% | 20.1% | ||
| Q4 24 | -2.2% | 20.1% | ||
| Q3 24 | 14.1% | 18.1% | ||
| Q2 24 | 22.3% | 22.6% |
净利率DOCPNR
| Q1 26 | 51.6% | 16.6% | ||
| Q4 25 | 73.2% | 16.3% | ||
| Q3 25 | -16.6% | 18.0% | ||
| Q2 25 | 4.6% | 13.2% | ||
| Q1 25 | 6.1% | 15.3% | ||
| Q4 24 | 0.7% | 17.1% | ||
| Q3 24 | 12.3% | 14.1% | ||
| Q2 24 | 21.0% | 16.9% |
每股收益（稀释后）DOCPNR
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $1.01 | ||
| Q3 25 | $-0.17 | $1.12 | ||
| Q2 25 | $0.05 | $0.90 | ||
| Q1 25 | $0.06 | $0.93 | ||
| Q4 24 | $0.02 | $0.99 | ||
| Q3 24 | $0.12 | $0.84 | ||
| Q2 24 | $0.21 | $1.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $67.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $7.8B | $3.8B |
| 总资产 | $21.6B | $7.1B |
| 负债/权益比越低杠杆越低 | — | 0.51× |
8季度趋势，按日历期对齐
现金及短期投资DOCPNR
| Q1 26 | $-1.2B | $67.7M | ||
| Q4 25 | $467.5M | — | ||
| Q3 25 | $91.0M | $128.4M | ||
| Q2 25 | $89.4M | $143.0M | ||
| Q1 25 | $70.6M | $140.6M | ||
| Q4 24 | $119.8M | $118.7M | ||
| Q3 24 | $180.4M | $218.1M | ||
| Q2 24 | $106.9M | $214.3M |
总债务DOCPNR
| Q1 26 | — | $1.9B | ||
| Q4 25 | $9.8B | $1.6B | ||
| Q3 25 | $9.1B | $1.6B | ||
| Q2 25 | $9.0B | $1.4B | ||
| Q1 25 | $8.9B | $1.8B | ||
| Q4 24 | $8.7B | $1.6B | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | $1.8B |
股东权益DOCPNR
| Q1 26 | $7.8B | $3.8B | ||
| Q4 25 | $7.5B | $3.9B | ||
| Q3 25 | $7.6B | $3.8B | ||
| Q2 25 | $7.9B | $3.7B | ||
| Q1 25 | $8.2B | $3.6B | ||
| Q4 24 | $8.4B | $3.6B | ||
| Q3 24 | $8.6B | $3.5B | ||
| Q2 24 | $8.8B | $3.4B |
总资产DOCPNR
| Q1 26 | $21.6B | $7.1B | ||
| Q4 25 | $20.3B | $6.9B | ||
| Q3 25 | $19.6B | $6.8B | ||
| Q2 25 | $19.8B | $6.5B | ||
| Q1 25 | $19.8B | $6.7B | ||
| Q4 24 | $19.9B | $6.4B | ||
| Q3 24 | $20.0B | $6.5B | ||
| Q2 24 | $20.2B | $6.5B |
负债/权益比DOCPNR
| Q1 26 | — | 0.51× | ||
| Q4 25 | 1.31× | 0.42× | ||
| Q3 25 | 1.20× | 0.42× | ||
| Q2 25 | 1.14× | 0.38× | ||
| Q1 25 | 1.08× | 0.51× | ||
| Q4 24 | 1.04× | 0.46× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | — |
| 自由现金流经营现金流 - 资本支出 | — | $-85.7M |
| 自由现金流率自由现金流/营收 | — | -8.3% |
| 资本支出强度资本支出/营收 | 3.4% | 1.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $716.0M |
8季度趋势，按日历期对齐
经营现金流DOCPNR
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $50.8M | ||
| Q3 25 | $315.0M | $196.3M | ||
| Q2 25 | $363.5M | $606.6M | ||
| Q1 25 | $279.4M | $-38.9M | ||
| Q4 24 | $1.1B | $86.5M | ||
| Q3 24 | $318.2M | $248.6M | ||
| Q2 24 | $316.2M | $539.2M |
自由现金流DOCPNR
| Q1 26 | — | $-85.7M | ||
| Q4 25 | $357.0M | $27.1M | ||
| Q3 25 | — | $178.9M | ||
| Q2 25 | — | $595.7M | ||
| Q1 25 | — | $-55.7M | ||
| Q4 24 | $333.7M | $63.8M | ||
| Q3 24 | — | $233.2M | ||
| Q2 24 | — | $522.2M |
自由现金流率DOCPNR
| Q1 26 | — | -8.3% | ||
| Q4 25 | 49.6% | 2.7% | ||
| Q3 25 | — | 17.5% | ||
| Q2 25 | — | 53.0% | ||
| Q1 25 | — | -5.5% | ||
| Q4 24 | 47.8% | 6.6% | ||
| Q3 24 | — | 23.5% | ||
| Q2 24 | — | 47.5% |
资本支出强度DOCPNR
| Q1 26 | 3.4% | 1.8% | ||
| Q4 25 | 124.4% | 2.3% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | 105.6% | 2.3% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.5% |
现金转化率DOCPNR
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | 0.31× | ||
| Q3 25 | — | 1.07× | ||
| Q2 25 | 11.48× | 4.08× | ||
| Q1 25 | 6.52× | -0.25× | ||
| Q4 24 | 235.43× | 0.52× | ||
| Q3 24 | 3.71× | 1.78× | ||
| Q2 24 | 2.17× | 2.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
PNR
| Water Solutions | $391.0M | 38% |
| Pool | $387.1M | 37% |
| Flow | $258.1M | 25% |
